AwardedUnited KingdomServices£395,807
Provision of Assay Kits for SCID Evaluation: EONIS-Q
- Published
- Published 22 April 2026
- Deadline
- Closed 31 March 2025
Overview
NHS England has awarded a contract to Revvity (UK) Limited for the provision of assay kits for SCID evaluation using the EONIS-Q methodology, valued at £949,936.80 for an 18-month period. The contract supports the delivery and implementation of the NHS Newborn Blood Spot SCID in-service evaluation across four screening laboratories, procured via a compliant Direct Award National framework.
Key details
- Country
- United Kingdom
- Status
- Awarded
- Category
- Services
- Estimated value
- £395,807
- Procedure
- Selective
- SME suitable
- No
- Published
- 22 April 2026
- Deadline
- Closed
Health services
Award outcome
- Awarded value
- £949,937
- Award date
- 21 April 2026
- Contract period
- 14 October 2025 → 31 March 2026
- Revvity (UK) Limited
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
22 April 2026
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.